Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colonic Neoplasms 7 Colorectal Neoplasms 6 Rectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Liver Neoplasms 2 Head and Neck Neoplasms 2 Hand-Foot Syndrome 2 Adenomatous Polyposis Coli 2 Smoking 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Pain 1 Nasopharyngeal Carcinoma 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Influenza, Human 1 Drug-Related Side Effects and Adverse Reactions 1 Breast Neoplasms, Male 1 Agnosia 1 Adenocarcinoma of Lung 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Smoking × Celecoxib × Clear all

NCT00981201 2012-08-01

Celecoxib as a Chemopreventive Agent in Current and Former Smokers

M.D. Anderson Cancer Center

Phase 3 Completed

Smoking

Data powered by HemOnc (CC BY 4.0) Colophon ⚡